Skip to main content
. 2023 Mar 5;15(5):1611. doi: 10.3390/cancers15051611

Table 2.

Summary of risk of bias in all the randomized controlled trials including the results reported by de Jonge et al. [12], Ram et al. [25], and Kumar et al. [22], and the results of the systematic review by Stern et al. [13]. The risk of bias included randomization sequence, concealment, blinding of participant and clinician, incomplete outcome data, selective reporting, and others. The color of risk of bias: green, low risk of bias; yellow, unclear risk of bias; red, high risk of bias.

Randomization
Sequence
Concealment Blinding of Participant
and
Clinician
Blinding of
Outcome Assessment
Incomplete Outcome Data Selective
Reporting
Others
our analysis de Jonge 2022 [12] low low high low low low low
Kumar 2020 [22] low low high low low low low
Ram 2021 [25] low low high unclear low unclear unclear
Stern analysis Aguilar-Guisado 2017 [19] low low high high low low low
Bjornsson 1977 [20] unclear unclear high high low high low
Klaassen 2000 [21] low low low low low low low
Pizzo 1979 [24] unclear unclear high high low high unclear
Pizzo 1982 [23] unclear unclear high high low high unclear
Rodriguez 1973 [26] unclear unclear high high low high unclear
Santolaya 1997 [28] unclear unclear high high low high unclear
Santolaya 2017 [27] unclear unclear high low low high low
low (%) 45.5 45.5 9.1 36.4 100.0 36.4 54.5
unclear (%) 54.5 54.5 0.0 9.1 0.0 9.1 45.5
high (%) 0.0 0.0 90.9 54.5 0.0 54.5 0.0